Japan Drug Makers Increasingly Use Super Computers For Development
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo, Astellas Pharma and other Japanese drug makers, are moving increasingly to the use of supercomputers for developing drugs, including cancer treatments.